Troy Wilson
President and CEO
oncology
Kura Oncology
United States of America
Biography
Troy Wilson, Ph.D., J.D. is one of our co-founders and has served as our President and Chief Executive Officer and as a member of our board of directors since August 2014. Dr. Wilson has served as President and Chief Executive Officer of Wellspring Biosciences LLC, a private biopharmaceutical company, and its parent company Araxes Pharma LLC since July 2012 and as President and Chief Executive Officer of Avidity NanoMedicines LLC, a private biopharmaceutical company, since November 2012.
Research Interest
oncology